CRIS Current Research Information System

RENZULLI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.374
NA - Nord America 6.260
EU - Europa 4.138
AF - Africa 415
SA - Sud America 344
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.161
VN - Vietnam 2.127
SG - Singapore 1.920
CN - Cina 1.756
IT - Italia 1.071
GB - Regno Unito 626
DE - Germania 537
HK - Hong Kong 505
SE - Svezia 462
IN - India 305
KR - Corea 248
FR - Francia 242
BR - Brasile 224
NL - Olanda 222
RU - Federazione Russa 181
IE - Irlanda 179
FI - Finlandia 143
CH - Svizzera 117
JP - Giappone 108
TG - Togo 103
CI - Costa d'Avorio 101
ZA - Sudafrica 81
CA - Canada 58
UA - Ucraina 58
BG - Bulgaria 56
ID - Indonesia 46
SC - Seychelles 46
NG - Nigeria 44
TH - Thailandia 44
JO - Giordania 42
AR - Argentina 41
PH - Filippine 40
PL - Polonia 40
TR - Turchia 38
BD - Bangladesh 37
AT - Austria 36
EE - Estonia 36
MX - Messico 31
PK - Pakistan 28
IQ - Iraq 25
MY - Malesia 23
BE - Belgio 22
TW - Taiwan 20
EG - Egitto 18
EC - Ecuador 17
HR - Croazia 16
CL - Cile 15
CO - Colombia 14
ES - Italia 13
LT - Lituania 12
UZ - Uzbekistan 12
VE - Venezuela 12
GR - Grecia 10
RO - Romania 10
SA - Arabia Saudita 10
PE - Perù 8
AU - Australia 7
MK - Macedonia 7
KE - Kenya 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CZ - Repubblica Ceca 5
PS - Palestinian Territory 5
PY - Paraguay 5
RS - Serbia 5
ET - Etiopia 4
IR - Iran 4
LV - Lettonia 4
OM - Oman 4
UY - Uruguay 4
BO - Bolivia 3
CR - Costa Rica 3
HU - Ungheria 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MA - Marocco 3
NZ - Nuova Zelanda 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
NP - Nepal 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
Totale 18.526
Salva come PNG Salva come JPEG
Città #
Singapore 1.394
Ashburn 792
Fairfield 580
Southend 525
Ho Chi Minh City 515
Chandler 511
Hanoi 461
Hong Kong 454
Hefei 433
San Jose 303
Bologna 294
Santa Clara 262
Houston 226
Wilmington 221
Woodbridge 220
Seoul 219
Seattle 212
Beijing 193
Dublin 179
Cambridge 167
Princeton 162
Dong Ket 155
Boardman 141
Los Angeles 137
Lomé 103
Bern 102
Lauterbourg 102
Abidjan 101
Milan 101
Council Bluffs 98
Helsinki 97
New York 97
Ann Arbor 95
Tokyo 86
Munich 85
Da Nang 84
Dallas 79
Haiphong 79
Rome 55
Sofia 54
Frankfurt am Main 49
Buffalo 48
The Dalles 48
Berlin 47
Nanjing 45
Westminster 45
Redmond 44
Redondo Beach 44
Bengaluru 43
Turin 43
Amman 42
Abeokuta 41
Florence 39
São Paulo 39
Bremen 38
Guangzhou 37
Shanghai 37
Johannesburg 35
Amsterdam 34
Orem 32
Padova 31
Jakarta 30
Turku 30
San Diego 29
Falkenstein 28
Falls Church 28
Hải Dương 28
Shenyang 28
Des Moines 27
Saint Petersburg 26
Warsaw 26
Jinan 25
Changsha 23
Tianjin 22
Brussels 21
Toronto 21
Chicago 20
Montreal 20
Nuremberg 20
Tongling 20
Washington 20
Hangzhou 19
Phoenix 19
Bangkok 18
London 18
Redwood City 18
Vienna 18
Can Tho 17
Hyderabad 17
Jacksonville 17
Atlanta 16
Bắc Ninh 16
Bến Tre 16
Lappeenranta 16
Nanchang 16
Biên Hòa 15
Düsseldorf 14
Medford 14
Zhengzhou 14
Brooklyn 13
Totale 11.838
Salva come PNG Salva come JPEG
Nome #
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis inintermediate-advanced hepatocellular carcinoma 313
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 287
Monofocal hepatocellular carcinoma: How much does size matter? 283
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
Ablation for hepatocellular carcinoma: beyond the standard indications 264
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 260
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 257
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 253
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep) 250
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 247
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 246
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 241
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 239
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas 237
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 234
Pattern of macrovascular invasion in hepatocellular carcinoma 233
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 228
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 219
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 218
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma 218
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4- related Diseases. A Case Report 216
The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time 212
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 208
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 207
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 205
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 202
The changing scenario of hepatocellular carcinoma in Italy: an update 200
LE PROPRIETÀ NASCOSTE NELL’IMMAGINE RM PER RILEVARE AUTOMATICAMENTE LA ZONA DI TRANSIZIONE TRA CARCINOMA RETTALE LOCALMENTE AVANZATO E TESSUTO SANO, E PREDIRE LA RISPOSTA ALLA TERAPIA NEO-ADIUVANTE 200
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 197
Transcatheter Embolization for Giant Splenic Artery Aneurisms: Still an Open Question 196
Uterine Artery Embolization for the Treatment of Symptomatic Uterine Fibroids of Different Sizes: A Single Center Experience 192
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 191
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 189
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study 188
Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib 186
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 186
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging 182
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 180
SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial 179
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma 176
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 174
COVID-19: Has the Liver Been Spared? 173
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. 172
Liver collision lesion: inflammatory hepatocellular adenoma within focal nodular hyperplasia 172
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm 169
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. 167
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 165
From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma 163
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 163
Association between anatomic variations of extrahepatic and intrahepatic bile ducts: Do look up! 161
Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT) 161
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 161
Definition of local recurrence site in resected pancreatic adenocarcinoma: A multicenter study (dolores-1) 161
A Splenic UFO: Intrasplenic Epithelioid Mesothelioma 159
Normothermic and hypothermic oxygenated perfusion for donation after circulatory death in kidney transplantation: Do we pay higher risk of severe infection after transplantation?: A case report 159
TACE performed in patients with a single nodule of Hepatocellular Carcinoma 155
Treatment of combined hepatocellular and cholangiocarcinoma 154
Gastric cancer staging: Is it time for magnetic resonance imaging? 154
Pseudoaneurysm of the splenic artery mimicking a solid lesion 153
Biliary Variant in a Potential Liver Donor 151
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. 151
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 148
Magnetic Resonance Enterography Reinvented: Exploring the Potential of a New Natural Beverage as an Alternative to Polyethylene Glycol Solution 148
Improved Survival after Transarterial Radioembolisation for Hepatocellular Carcinoma Gives the Procedure Added Value 148
Large regenerative nodules in a patient with Budd-Chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRI 147
Proposal of standardization of every step of angiographic procedure in bleeding patients from pelvic trauma 147
Experience with regorafenib in the treatment of hepatocellular carcinoma 147
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 145
Neuroendocrine pancreatic cancer: diagnosis and characterization with spiral computer tomography and nuclear magnetic resonance. 144
Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? 142
null 142
Venous outflow in partial heterotopic liver transplantation with spleen replacement: Evidence of no chronic venous hypertension 142
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 141
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 139
Prognostic Role of Early Cardiac Magnetic Resonance in Myocardial Infarction With Nonobstructive Coronary Arteries 138
MANUALE DI DIAGNOSTICA PER IMMAGINI PER IL CORSO DI LAUREA IN MEDICINA E CHIRURGIA. DIAGNOSTICA PER IMMAGINI DEL FEGATO, DELLA MILZA, DEL PERITONEO E MESENTERE. 2°edizione CAPITOLO 8 - 10 - 13 138
LI-RADS: a great opportunity not to be missed 138
Two surgical techniques are better than one: RAVAS and RAPID are answers for the same issue 137
Radiological Features of Microvascular Invasion of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease 136
False in Name Only—Gastroduodenal Artery Pseudoaneurysm in a Recurrently Bleeding Patient: Case Report and Literature Review 135
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure 133
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 133
Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning 133
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma 132
Non-invasive tests for the prediction of primary hepatocellular carcinoma 130
Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases. 129
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions 128
Pathobiological and Radiological Approach For Hepatocellular Carcinoma Subclassification 127
Pneumatosis intestinalis and spontaneous perforation associated with drug toxicity in oncologic patients: A case series 127
SAT-453-Effects of sorafenib on pancreatic volume and their clinical implications in patients with hepatocellular carcinoma 126
Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma 120
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 120
Contrast-enhanced ultrasound LI-RADS LR-5 in hepatic tuberculosis: Case report and literature review of imaging features 119
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 118
Tumor-associated macrophages and inflammatory microenvironment in gastric cancer: Novel translational implications 118
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 117
Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role 116
Outcome of post liver transplant ischemic and non-ischemic biliary stenosis treated with percutaneous interventions:the Bologna experience. 113
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 109
Gastric melanoma of unknown primary 107
Totale 17.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021530 0 0 0 0 0 0 0 0 0 73 77 380
2021/20221.822 100 34 91 102 169 91 45 138 85 120 569 278
2022/20232.240 166 291 94 287 153 190 104 138 410 61 168 178
2023/2024949 68 127 63 92 98 217 38 70 48 41 60 27
2024/20253.304 173 401 314 254 389 179 293 140 55 289 236 581
2025/20267.494 908 836 626 560 667 369 1.268 251 1.499 510 0 0
Totale 18.947